Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4094 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Kiss and tell study highlights meningitis concern

The Australian researchers conclude that the study, published in the British Medical Journal, highlights the need for development of further effective meningococcal vaccines. The incidence and fatality rate

Pfizer asks FDA to recall Zithromax generic versions

The world’s biggest drug maker Pfizer alleges that the drugs contain significant amounts of azithromycin sesquihydrate rather than the azithromycin monohydrate that they claim in their labels. Pfizer’s

NeurogesX pain patch demonstrates efficacy in trial

The study evaluated the effect of a single application of NGX-4010 (transacin), the company’s novel high-concentration trans-capsaicin dermal patch, on pain due to HIV-associated sensory neuropathy (HIV-AN). The

Debiopharm drug shows promise in HIV study

The aim of the study was to assess the safety of repeated oral doses of Debio-025, to determine its pharmacokinetic profile and antiviral effect in the patients. The

Gilead HIV treatment shown to be safe as a gel

Microbicides are designed to prevent the sexual transmission of HIV and other sexually transmitted diseases and may be formulated as vaginal gels, foams, creams, or suppositories. Published in

Averion and Siplas enter marketing partnership

This agreement represents a working relationship that will involve joint marketing efforts and a mutual contracting of complementary products and services from both companies to biotechnology, pharmaceutical and

Gastrotech begins new cancer study

The study is designed as a double blind, randomized, controlled study in 30 patients with end-stage cancer and significant weight loss. The study follows the recent completion of